Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by 4Justiceon Feb 06, 2021 11:56am
132 Views
Post# 32492964

NICE LIES CAME IN

NICE LIES CAME INNEWCAMO, 

Liminal decided to stop spending money into the plasma division. They don't operate the fractionation plan in Laval anynore. The CMC has not been approuved and the postponement of the PDUFA to June 5th means that FDA requirements have not been met. In 2 words FORGET APPROUVAL. Don't mislead anybody.

About 4050 the only on going project is a phase 1 to evaluate dosing !!! Everything else is on HOLD,


<< Previous
Bullboard Posts
Next >>